O7 Spółka z Ograniczoną Odpowiedzialnością (KRS 0000865217, NIP 9512508930) is a Polish company, headquartered in Warszawa, Mazowieckie voivodeship. O7 operates in: Wholesale of perfume and cosmetics (PKD 46.45.Z). Industry: Wholesale trade. The company has been listed in the National Court Register since October 19, 2020. O7's most recently reported net revenue was 681.0 K PLN for 2024.
Negative equity
Negative equity in 5 of 7 available reporting years.
No arrears identified in the analyzed sources
No arrears or bankruptcy proceedings identified in the analyzed sources.
Business profile - O7
Identity
- Name
- O7 Spółka z Ograniczoną Odpowiedzialnością
- Legal form
- SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
- Founded
- October 19, 2020
- Registry status as of
- December 3, 2025
- Latest entry
- April 15, 2025
- Founding act
- 15.10.2020 R.
Articles of association history (2)
- October 15, 2020: 15.10.2020 R.
- March 28, 2025: 28.03.2025R., REPERTORIUM A NR 1865/2025, NOTARIUSZ WŁADYSŁAW LEWANDOWSKI, KANCELARIA NOTARIALNA BARTOSZ LEWANDOWSKI, WŁADYSŁAW LEWANDOWSKI W WARSZAWIE, ZMIENIONO: § 2, § 4,
Activities
Main activity
46.45.ZWholesale of perfume and cosmetics
Other activities
Address and contact
- Address
- UL. POLKI, 3C, 21, 02-826, WARSZAWA, POLSKA
- Voivodeship
- MAZOWIECKIE
- District
- WARSZAWA
- Not disclosed in the registry
- Website
- Not disclosed in the registry
- E-delivery address
- Not disclosed in the registry
- Coordinates
- 52.2298, 21.0117approx.
Risk and payment profile - O7
Credibility rating
40.3 / 100
Average credibility
Insolvency risk
Low
Elevated threat
Closure risk
12
/ 100
Risk comparison - scale 0 (safe) → 100 (critical)
Organizational stability signals
No instability signals - ownership, management, PKD codes and company name remain relatively stable.
Shareholder changes
2
2/6 yrs
Board changes
2
2/6 yrs
PKD changes
1
1/6 yrs
Name changes
1
1/6 yrs
Data from 6 years of registry activity.
Credibility history
Payment reliability score from 2018–2024
Current: D (40/100)
Trend: deteriorating (-2.7 pts/year)
Słaba wiarygodność płatnicza – wskaźniki finansowe sugerują podwyższone ryzyko opóźnień lub niewykonania zobowiązań.
Trade credit limit history
Standard limit from 2018–2024
Current: 19.5 K PLN
Safe: 5.8 K PLN
Operational status - O7
Founded
October 19, 2020
5 years in operation
Legal form
SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
Registry: RejP
Headquarters
WARSZAWA
MAZOWIECKIE
Primary PKD
46.45.Z
Wholesale of perfume and cosmetics
Share capital
5.0 K PLN
92 shares total
Shareholders
1
shareholder
Board
1 person
Filed years
7 years
2018–2024 · profitable: 4/7
Registry entries
11
latest: April 15, 2025
Risk signals
Revenue
681.0 K PLN
2024
Net profit
13.8 K PLN
2024
Assets
285.7 K PLN
2024
Equity
19.6 K PLN
2024
Valuation
160.5 K PLN
Medium confidence
Companies in the same location
Public procurement
Trademarks
Reviews
Rate business credibility - O7.
No ratings
Related articles
Explainer
Eurocash in 2026: Polish FMCG-wholesale leader and Delikatesy Centrum network, an mWIG40 issuer near Poznań, controlled by Luis Amaral
Eurocash S.A. (KRS 0000213765), headquartered at ul. Wiśniowa 11 in Komorniki near Poznań, is the leader of Poland's FMCG-wholesale distribution and the operator of the 1,500+ Delikatesy Centrum store network. Founded in 1995 by Portuguese entrepreneur Luis Amaral, listed on the WSE since 2005, the company is an mWIG40 constituent. A six-member management board, a five-member supervisory board, chaired by the founder himself.
Explainer
Mercator Medical in 2026: a Kraków-based medical-glove producer with plants in Thailand, an mWIG40 issuer after the COVID meme-stock cycle
Mercator Medical S.A. (KRS 0000036244), headquartered at ul. Modrzejewskiej 30 in Kraków, is a Polish producer and distributor of single-use medical gloves (nitrile and latex) and other disposables. The company controls the full value chain: plants in Thailand (Mercator Medical Thailand) plus Polish and international distribution. In 2020 the share price exploded on pandemic demand (from PLN 10 to over PLN 800), followed by cautious normalisation. Listed on the WSE since 2013. A three-member management board, a five-member supervisory board.
